Side Effects of emapalumab-lzsg injection: A Synthesis of Findings from 3 Studies
- Home
- Side Effects of emapalumab-lzsg injection
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of emapalumab-lzsg injection: A Synthesis of Findings from 3 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Efavirenz, a commonly used antiretroviral drug, has been associated with neurological side effects in over 50% of patients. 1 and 3 both point to the prevalence of these effects. A study 1 specifically looked at the impact of efavirenz on neuropsychological performance and found that while neuropsychological performance improved over time for both groups (those taking efavirenz and those not), there was no significant difference between the groups. However, those taking efavirenz experienced more neurological symptoms during the first week of therapy. The same study also found that efavirenz was associated with more "bad dreams" during the first week of therapy. 3 is a review of studies on efavirenz-induced neuropsychiatric side effects and reports that the most common side effects include reduced sleep quality, depression, dizziness, and anxiety. These side effects are generally mild and do not require discontinuation of efavirenz. However, it is important to note that these studies did not include all patient groups, such as the elderly, children, patients with active symptomatic illness, and especially African women.
Reasons for Side Effects
A systematic review 2 explores the potential neuronal toxicity of efavirenz. This review suggests that efavirenz may contribute to cognitive impairment by damaging nerve cells. While the clinical evidence is weak, it indicates that efavirenz may worsen neurocognitive impairment or be associated with less improvement in neurocognitive impairment compared to other antiretrovirals. Efavirenz, especially its major metabolite, 8-hydroxy-efavirenz, has been shown to be toxic to neuron cultures at concentrations found in cerebrospinal fluid. This suggests that individuals who metabolize efavirenz extensively may be more susceptible to efavirenz toxicity due to the formation of more 8-hydroxy-efavirenz. Several potential mechanisms for efavirenz neurotoxicity have been proposed, including altered calcium hemostasis, decreased brain creatine kinase, mitochondrial damage, increased brain proinflammatory cytokines, and involvement of the cannabinoid system.
Common Side Effects
Sleep Quality
Both 1 and 3 found that efavirenz can negatively affect sleep quality. Specifically, individuals taking efavirenz reported experiencing more "bad dreams" during the first week of therapy. The review in 3 also confirmed reduced sleep quality as a common side effect.
Depression
The 3 review found that depression was a commonly reported side effect of efavirenz. However, these side effects were generally mild and did not necessitate discontinuation of efavirenz.
Dizziness
The 3 review found that dizziness was a commonly reported side effect of efavirenz. However, these side effects were generally mild and did not necessitate discontinuation of efavirenz.
Anxiety
The 3 review found that anxiety was a commonly reported side effect of efavirenz. However, these side effects were generally mild and did not necessitate discontinuation of efavirenz.
Side Effect Countermeasures
Sleep Disturbances
If you experience sleep problems, consult your doctor for appropriate treatment. They may prescribe medications like sleeping pills or melatonin supplements. It's also important to make lifestyle changes, such as avoiding caffeine before bed, setting aside time to relax before sleep, and maintaining a regular sleep schedule.
Depression
If you experience symptoms of depression, talk to your doctor. Treatment options include antidepressants or counseling. Depression can worsen if left untreated, so it's important to seek treatment early.
Dizziness
If you feel dizzy, take caution when getting up or walking. It's also important to stay hydrated. If your dizziness is severe, consult your doctor.
Anxiety
If you experience significant anxiety, talk to your doctor. There are medications to reduce anxiety and therapies like cognitive behavioral therapy. Trying relaxation techniques like deep breathing or meditation can also be helpful in easing anxiety.
Comparison Between Studies
Similarities Between Studies
The studies generally agree that efavirenz can cause neurological side effects, and that these side effects are often mild and do not require discontinuation of the medication. However, these studies did not include all patient groups, such as the elderly, children, patients with active symptomatic illness, and especially African women. More research is needed to understand the impact of efavirenz in these populations.
Differences Between Studies
The 1 study focused on the direct impact of efavirenz on neuropsychological performance and found no significant differences between those taking efavirenz and those not taking it. The 3 review, however, provided a broader perspective, summarizing findings across multiple studies on efavirenz-induced neuropsychiatric side effects.
Points to Note for Applying Research to Real Life
Efavirenz is an important treatment for people with HIV. However, it's crucial to remember that efavirenz can cause neurological side effects. Therefore, it's essential to follow your doctor's instructions and take efavirenz at the correct dosage and in the prescribed way. If you experience any side effects from efavirenz, consult your doctor.
Limitations of Current Research
These studies did not include all patient groups, such as the elderly, children, patients with active symptomatic illness, and especially African women. Therefore, further research is needed to understand the impact of efavirenz in these populations. Additionally, these studies have not fully elucidated the mechanism of efavirenz neurotoxicity.
Future Directions for Research
Further research is needed to understand the mechanism of efavirenz neurotoxicity. Studies should also include all patient groups, such as the elderly, children, patients with active symptomatic illness, and especially African women. Developing new therapies or preventive measures to reduce neurological side effects caused by efavirenz administration is also necessary.
Conclusion
Efavirenz is an effective treatment for people with HIV, but it's important to remember that it can cause neurological side effects. If you experience side effects, talk to your doctor. Further research is important to gain a deeper understanding of the safety and efficacy of efavirenz.
Article Type
Author: CliffordDavid B, EvansScott, YangYijun, AcostaEdward P, GoodkinKarl, TashimaKaren, SimpsonDavid, DorfmanDavid, RibaudoHeather, GulickRoy M
Language : English
Author: DecloedtEric H, MaartensGary
Language : English
Author: GaidaRazia, TruterIlse, GroblerChristoffel, KotzeTheunis, GodmanBrian
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.